Beckman Coulter's new urinalysis solution improves laboratory workflow by significantly reducing manual reviews to 4% and cutting sample processing time by up to 78%

- Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines urinalysis workflow and reduces manual reviews to 4%. The new workcell will be showcased in a live launch event held in the AACC Expo hall, booth 1523, and live streamed via LinkedIn on September 28, 2021 at 12 p.m. EDT 9 a.m. PDT .

A routine urinalysis is one the most frequently ordered tests, representing up to 30% of all samples received in the lab 3 . Many of these samples require a lab technician to perform a manual inspection, which causes workflow disruption and a substantial increase in workload. Whether it is confirming the analyzer's findings or identifying unique particle types, manual microscopic reviews are time-consuming and can take up to six times longer per sample than with an automated system 4 .

Automating the routine urinalysis workflow with the DxU Iris Workcell reduces sample subjectivity and variability, helping laboratories of all sizes standardize processes, drive faster turnaround time and deliver quality results.

"There is no doubt that the pandemic has intensified pressure on the clinical laboratory," said Dr. Peter Soltani , senior vice president & general manager, hematology, urinalysis & workflow information technology solutions at Beckman Coulter. "In this pressurized environment, manual reviews are particularly onerous because they are labor-intensive, taking time and focus away from scientific work. We designed the DxU Iris Workcell to allow urinalysis operators to automatically classify sediment particles, minimizing the need for human intervention."

The DxU Iris Workcell pairs the DxU 850m Iris or DxU 840m Iris urine microscopy analyzer with the Arkray AUTION MAX™ 4030 urine chemistry analyzer to create a scalable, fully automated urinalysis solution. The workcell was developed with proprietary Digital Flow Morphology technology with Auto-Particle Recognition (APR) Software to enable laboratories to deliver standardized results using artificial intelligence (AI). This industry-leading technology isolates, identifies and characterizes urine particles to provide immediate, accurate and reproducible results verified directly on the screen.

"As a Med Tech, it's important for me that any new analyzer we bring into the lab makes the workflow better and is easy to use with minimal maintenance. The DxU Iris has several features that can help med techs work more efficiently. One such feature is that the user guide with the key reference information is on the main screen," said Jennifer Soria , a hematology section coordinator for a medical group in Florida . "I love the new Load and Unload station as it can hold multiples racks, allowing users to work in other areas of the lab while processing urine samples."

The DxU Iris Workcell is designed for high-volume laboratories and features:

  • An optional Load and Unload station that increases the capacity of racks for a total of 190 onboard samples
  • Intuitive software user interface to comfortably navigate the analyzer menu, access key reference information and simplify user training in a format aligned across multiple Beckman Coulter instruments including hematology, chemistry and immunoassay
  • Connectivity with Beckman Coulter's advanced informatics software solutions: PRO Service remote service tool, DxONE Command Central remote monitoring, and REMISOL Advance middleware

To learn more about Beckman Coulter's DxU Iris Workcell and other urinalysis solutions, visit the website at .

Members of the media can access the online press kit for the DxU Iris Workcell, including videos, images, and other assets at .

About Beckman Coulter
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology, and the passion and creativity of our teams to enhance the diagnostic laboratory's role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing and found in hospitals, reference laboratories, and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes, and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics, and unlocking hidden value through performance partnership. A subsidiary of Danaher Corporation (NYSE: DHR) since 2011, Beckman Coulter, Inc. is headquartered in Brea, Calif. , and has more than 11,000 global associates working diligently to make the world a healthier place.

© 2021 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2021-9662

ARKRAY, the stylized logo, and the ARKRAY products mentioned herein are trademarks or registered trademarks of ARKRAY in the United States .

REMISOL Advance is a trademark or registered trademark of Normand-Info SAS in the United States and other countries. Used under license.

1 Broadlawns Medical Center. (2019). Manual microscopy divided by on-screen microscopic verification report generated December 20, 2019 . A case study published by Beckman Coulter. .
2 Beaufort Memorial Urinalysis Workflow Case Study, CS-52048.
3 Delanghe, J., & Speeckaert, M. (2014). Preanalytical requirements of urinalysis. Biochemia Medica, 24(1), 89–104.
4 [Accessed: August 2, 2021 ]

DxU Iris Workcell

DxU Iris Workcell

DxU Iris Workcell

Beckman Coulter logo. (PRNewsfoto/Beckman Coulter)

Cision View original content to download multimedia:

SOURCE Beckman Coulter Diagnostics

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt

Share of 127-megawatt aggregated deal in collaboration with Eurofins Scientific will power over half of Thermo Fisher's addressable European footprint with 100% renewable electricity by 2025

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 15-year virtual power purchasing agreement (VPPA) with international solar developer ib vogt . Thermo Fisher's 91-megawatt portion of the Serbal solar project will deliver approximately 192,000 megawatt hours of renewable electricity annually. Eurofins Scientific , a global leader in bioanalytical testing, collaborated in the aggregated deal for a 36-megawatt portion of the project.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Medtronic LABS: The Vital Role Of Community Health Workers


Reducing health disparities in a meaningful, sustainable, and scalable way

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation Awareness Day

Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) today announced they are joining forces to declare Tuesday, Dec. 5, Opioid-Induced Constipation (OIC) Awareness Day. OIC Awareness Day aims to bring awareness to an often-overlooked side effect of opioids. This day will help patients suffering from OIC by breaking down the stigma and silence surrounding this condition

"OIC Awareness Day will help bridge the gap between healthcare providers (HCPs), patients, and caregivers by providing them with the information needed to guide conversations about symptoms and management strategies," said Megan Filoramo, RN, MSN, APN-C. "I'm excited to be a part of this awareness initiative and help shed light on this underdiagnosed patient population."

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Medtronic Earns Equality 100 Award for LGBTQ+ Workplace Inclusion

Human Rights Campaign Foundation recognizes the company's ongoing commitment to inclusion, diversity, and equity

Recognizing the company's ongoing commitment to inclusion, diversity, and equity (ID&E) and the LGBTQ+ community, Medtronic earned a top score of 100 again this year on the Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Offer Now Scheduled to Expire at 5:00 p.m., New York Time, on December 14, 2023

Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs" and, together with the Shares, the "Offer Securities"), of Olink Holding AB (publ) ("Olink") for $26.00 per Share and per ADS, in cash.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Medtronic LABS: Opening Up Software To Expand Access to Healthcare


Medtronic LABS makes its digital health platform open source

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News